Panacea Biotec and Sanofi Healthcare India have reached a settlement agreement over a patent infringement lawsuit concerning a fully liquid hexavalent vaccine. Sanofi has agreed not to launch its ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

To address this issue, researchers funded by China’s Key Technologies R&D Program—under the country’s Ministry of Science and ...

Mar. 25, 2025 — Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new ...

Panacea Biotec Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 2,697.79 Crore) operating in Pharmaceuticals sector. Panacea Biotec Ltd. key Products/Revenue ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

After hours: March 26 at 7:59:05 PM EDT Loading Chart for SANA ...

FTSE 100 Index 8,689.59 25.79 0.30% ...

German biotechnology company Miltenyi Biotec has said that its CAR-T therapy, ZAMTO Cell, for B-cell lymphoma, is expected to be available in India by early 2026. CAR-T (Chimeric Antigen Receptor ...

The sudden withdrawal of almost half of global funding for nutrition suddenly will have dire consequences for decades.